ASSEMBLY BIOSCIENCES, INC.
ASMB· Nasdaq· Pharmaceutical Preparations
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- -56.9%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- -1.8%
We record prices for the companies we cover; ASMB is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 11.2M
- Revenue
- $72.3M
- Free cash flow
- -$41.2M
- Owner earnings
- -$45.8M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- –
- Operating
- -16.8%
- Net
- -8.5%
- Free cash flow
- -56.9%
- Owner earnings
- -63.4%
- Stock pay
- 6.5%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- -3.0%
- ROE, 5 yr avg
- -92.4%
Growth (CAGR)
- Revenue, 3 yr
- –
- Revenue, 5 yr
- -1.8%
- Revenue, 9 yr
- –
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Diluted EPS, 9 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
- Free cash flow, 9 yr
- –
Financial health · FY2025
- Cash and investments
- $248.1M
- Total debt
- –
- Net cash
- –
- Debt/Equity
- –
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- –
Financials: ten years from the 10-Ks
Revenue
$72.3M
FY2025
FY2016FY2025
Margins
Operating-16.8%Net-8.5%
FY2025
FY2016FY2025
Free cash flow and owner earnings
Free cash flow-$41.2MOwner earnings-$45.8M
FY2025
FY2016FY2025
Diluted shares
11.2M
+210.8% over 9 years, net dilution
FY2016FY2025
Every figure, year by year
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| The business | ||||||||||
| Revenue | $0 | $9.0M | $14.8M | $16.0M | $79.1M | $6.3M | $0 | $7.2M | $28.5M | $72.3M |
| Revenue growth | – | – | 64.1% | 7.8% | 395.6% | -92.1% | -100.0% | – | 298.2% | 153.5% |
| Gross margin | – | – | – | – | – | – | – | – | – | – |
| Operating margin | – | -579.1% | -626.4% | -643.4% | -81.9% | -2121.7% | – | -902.5% | -159.3% | -16.8% |
| Net income | -$44.3M | -$42.8M | -$90.8M | -$97.6M | -$62.2M | -$129.9M | -$93.1M | -$61.2M | -$40.2M | -$6.1M |
| Net margin | – | -474.7% | -613.0% | -611.6% | -78.6% | -2076.4% | – | -854.8% | -140.9% | -8.5% |
| Diluted EPS | – | – | – | – | – | $-36.00s | $-23.08 | $-13.38 | $-6.69 | $-0.55 |
| Return on invested capital? | – | – | – | – | – | – | – | – | – | – |
| Cash | ||||||||||
| Operating cash flow | -$34.9M | $1.9M | -$65.0M | -$84.1M | -$63.0M | -$93.4M | -$84.5M | $22.7M | -$51.1M | -$41.1M |
| Capital expenditure | $147.0K | $865.0K | $340.0K | $1.6M | $470.0K | $3.1M | $102.0K | $255.0K | $28.0K | $66.0K |
| Free cash flow | -$35.0M | $995.0K | -$65.3M | -$85.6M | -$63.4M | -$96.5M | -$84.6M | $22.5M | -$51.1M | -$41.2M |
| Stock-based compensation | $5.0M | $8.6M | $28.5M | $20.6M | $21.9M | $5.2M | $6.6M | $5.1M | $3.1M | $4.7M |
| Owner earnings? | -$40.1M | -$7.6M | -$93.8M | -$106.2M | -$85.3M | -$101.7M | -$91.2M | $17.4M | -$54.3M | -$45.8M |
| Free cash flow per share | – | – | – | – | – | $-26.75 | $-20.96 | $4.91 | $-8.52 | $-3.67 |
| Capital allocation | ||||||||||
| Dividends paid | – | – | – | – | – | – | – | – | – | – |
| Share repurchases | – | – | – | – | – | – | – | – | – | – |
| Diluted shares | – | – | – | – | – | 3.6Ms | 4.0M | 4.6M | 6.0M | 11.2M |
| Share count change? | – | – | – | – | – | – | 11.9% | 13.5% | 31.2% | 86.7% |
| Balance sheet | ||||||||||
| Cash and equivalents | $28.6M | $82.0M | $41.5M | $46.7M | $59.4M | $45.6M | $52.4M | $19.8M | $38.3M | $58.5M |
| Short-term investments | $24.4M | $37.9M | $176.6M | $227.3M | $157.0M | $101.0M | $39.2M | $110.4M | $73.7M | $189.7M |
| Total debt | – | – | – | – | – | – | – | – | – | – |
| Net debt | – | – | – | – | – | – | – | – | – | – |
| Shareholders' equity | $79.9M | $113.1M | $210.7M | $273.2M | $240.6M | $168.9M | $82.7M | $41.1M | $33.4M | $206.8M |
Latest filings
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-05-07 | 10-Q | Quarterly report |
| 2026-05-07 | 8-K | Earnings release |
| 2026-04-22 | DEF 14A | Proxy statement |
| 2026-03-19 | 10-K | Annual report |
| 2026-03-19 | 8-K | Earnings release |
| 2025-11-10 | 10-Q | Quarterly report |
| 2025-11-10 | 8-K | Earnings release |
| 2025-08-06 | 10-Q | Quarterly report |
| 2025-08-06 | 8-K | Earnings release |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
